These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37801493)

  • 41. Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets.
    Zhang Y; You C; Pei Y; Yang F; Li D; Jiang YZ; Shao Z
    J Transl Med; 2022 Jun; 20(1):256. PubMed ID: 35672824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.
    Hou Y; Nitta H; Wei L; Banks PM; Portier B; Parwani AV; Li Z
    Breast Cancer Res Treat; 2017 Nov; 166(2):447-457. PubMed ID: 28799059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities.
    Kalasekar SM; VanSant-Webb CH; Evason KJ
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
    Wu J; Li B; Sun X; Cao G; Rubin DL; Napel S; Ikeda DM; Kurian AW; Li R
    Radiology; 2017 Nov; 285(2):401-413. PubMed ID: 28708462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinoma.
    Huang A; Wang YP; Wang J; Fu PY; Zhang X; Cao Y; Fan J; Yang XR; Zhou J
    J Gastrointest Oncol; 2020 Feb; 11(1):112-120. PubMed ID: 32175113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated breast cancer genomics.
    Edgren H; Kallioniemi O
    Cancer Cell; 2006 Dec; 10(6):453-4. PubMed ID: 17157784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
    Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
    PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Systematic Pan-Cancer Analysis of Genetic Heterogeneity Reveals Associations with Epigenetic Modifiers.
    de Matos MR; Posa I; Carvalho FS; Morais VA; Grosso AR; de Almeida SF
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30897760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
    Kim M; Lee S; Lim S; Kim S
    PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot Study.
    Alberts D; Pottier C; Smargiasso N; Baiwir D; Mazzucchelli G; Delvenne P; Kriegsmann M; Kazdal D; Warth A; De Pauw E; Longuespée R
    Proteomics Clin Appl; 2018 Jan; 12(1):. PubMed ID: 28801933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
    Yamamoto S; Maki DD; Korn RL; Kuo MD
    AJR Am J Roentgenol; 2012 Sep; 199(3):654-63. PubMed ID: 22915408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
    Reuben A; Gittelman R; Gao J; Zhang J; Yusko EC; Wu CJ; Emerson R; Zhang J; Tipton C; Li J; Quek K; Gopalakrishnan V; Chen R; Vence LM; Cascone T; Vignali M; Fujimoto J; Rodriguez-Canales J; Parra ER; Little LD; Gumbs C; Forget MA; Federico L; Haymaker C; Behrens C; Benzeno S; Bernatchez C; Sepesi B; Gibbons DL; Wargo JA; William WN; Swisher S; Heymach JV; Robins H; Lee JJ; Sharma P; Allison JP; Futreal PA; Wistuba II; Zhang J
    Cancer Discov; 2017 Oct; 7(10):1088-1097. PubMed ID: 28733428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
    Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
    Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis.
    Natrajan R; Sailem H; Mardakheh FK; Arias Garcia M; Tape CJ; Dowsett M; Bakal C; Yuan Y
    PLoS Med; 2016 Feb; 13(2):e1001961. PubMed ID: 26881778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer.
    Yun JW; Lee S; Ryu D; Park S; Park WY; Joung JG; Jeong J
    Transl Oncol; 2019 Jan; 12(1):43-48. PubMed ID: 30265975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma.
    Chen S; Xie Y; Cai Y; Hu H; He M; Liu L; Liao C; Wang Y; Wang J; Ren X; Zeng Q; Peng H; Shen S; Li S; Li D; Lai J; Peng B; Ren J; Kuang M; Peng S
    Clin Cancer Res; 2022 May; 28(9):1896-1910. PubMed ID: 34526363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma.
    Lin P; Liu WK; Li X; Wan D; Qin H; Li Q; Chen G; He Y; Yang H
    Clin Radiol; 2020 Jul; 75(7):561.e1-561.e11. PubMed ID: 32183997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles.
    Li M; Zhang Z; Li L; Wang X
    Commun Biol; 2020 Sep; 3(1):505. PubMed ID: 32917965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.